ArticlePloS one2022

Efficacy of liquid biopsy for disease monitoring and early prediction of tumor progression in EGFR mutation-positive non-small cell lung cancer.

Hsiang-Ling Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.